Hyperphosphorylated tau in young and middle-aged subjects.

Area of Science:

• Neuroscience
• Neuropathology

Background:

• Neurodegenerative diseases, such as Alzheimer's, are characterized by protein aggregates like hyperphosphorylated tau (HPτ) and beta-amyloid (Aβ).
• The prevalence and progression of these pathologies in cognitively unimpaired individuals, particularly at younger ages, remain incompletely understood.

Purpose of the Study:

• To investigate the occurrence of HPτ and Aβ pathology in the brains of cognitively unimpaired young to middle-aged adults.
• To explore the potential link between early-life neurodegeneration and the development of symptomatic neurological disorders.

Main Methods:

• Immunohistochemical assessment of brain tissue from 95 cognitively unimpaired subjects (ages 22-50).
• Analysis focused on hyperphosphorylated tau (HPτ) and beta-amyloid (Aβ) pathology in specific neuroanatomical regions, including the transentorhinal cortex and locus coeruleus (LC).

Main Results:

• HPτ pathology was detected in 33% of subjects, often localized to the transentorhinal cortex and/or locus coeruleus (LC), without known risk factors.
• Notably, 30% of subjects exhibited HPτ pathology in the LC, independent of cortical Aβ or transentorhinal HPτ.
• These findings were observable even in single, thin tissue sections.

Conclusions:

• Neurodegenerative changes are surprisingly prevalent in cognitively unimpaired young and middle-aged individuals.
• The presence of early-life pathology does not invariably lead to symptomatic disease, suggesting the involvement of modifying factors.
• The frequent involvement of the LC in HPτ pathology highlights its potential role in mood disorders and warrants further clinicopathological investigation in younger populations.